342 related articles for article (PubMed ID: 15224468)
21. [The COMBO project. Criteria and guidelines for the combined treatment of type 2 diabetes. Consensus document (I)].
Goday Arno A; Franch Nadal J; Mata Cases M;
Aten Primaria; 2001 Feb; 27(3):197-206. PubMed ID: 11262327
[No Abstract] [Full Text] [Related]
22. Insulin initiation in Type 2 diabetes.
Page S
Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
[No Abstract] [Full Text] [Related]
23. Seeking sweet relief for diabetes.
Dove A
Nat Biotechnol; 2002 Oct; 20(10):977-81. PubMed ID: 12355109
[No Abstract] [Full Text] [Related]
24. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
Charbonnel B
Int J Clin Pract Suppl; 2007 Jun; (153):1-2. PubMed ID: 17594387
[No Abstract] [Full Text] [Related]
25. Oral agents in the management of type 2 diabetes mellitus.
Luna B; Feinglos MN
Am Fam Physician; 2001 May; 63(9):1747-56. PubMed ID: 11352285
[TBL] [Abstract][Full Text] [Related]
26. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
Hermansen K; Mortensen LS
Drug Saf; 2007; 30(12):1127-42. PubMed ID: 18035865
[TBL] [Abstract][Full Text] [Related]
27. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
Inzucchi SE
Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
[No Abstract] [Full Text] [Related]
28. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
[No Abstract] [Full Text] [Related]
29. Diabetes mellitus. Medication update.
Slagle M
South Med J; 2002 Jan; 95(1):50-5. PubMed ID: 11827245
[No Abstract] [Full Text] [Related]
30. [Therapies for newly-onset diabetic patients].
Kawamori R
Nihon Rinsho; 2005 Feb; 63 Suppl 2():525-32. PubMed ID: 15779435
[No Abstract] [Full Text] [Related]
31. Use of antidiabetic drugs in elderly patients.
Doucet J
Diabetes Metab; 2005 Dec; 31 Spec No 2():5S98-5S104. PubMed ID: 16415772
[TBL] [Abstract][Full Text] [Related]
32. Oral antihyperglycemic therapy for type 2 diabetes mellitus.
Cheng AY; Fantus IG
CMAJ; 2005 Jan; 172(2):213-26. PubMed ID: 15655244
[TBL] [Abstract][Full Text] [Related]
33. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
[No Abstract] [Full Text] [Related]
34. Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.
Tahrani AA; Barnett AH; Bailey CJ
Nat Rev Endocrinol; 2016 Oct; 12(10):566-92. PubMed ID: 27339889
[TBL] [Abstract][Full Text] [Related]
35. [Combined insulin and sulfonylurea treatment in diabetes mellitus].
Ravina A; Minuhin O
Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394
[No Abstract] [Full Text] [Related]
36. Oral antihyperglycemic therapy for type 2 diabetes: clinical applications.
Holmboe ES
JAMA; 2002 Jan; 287(3):373-6. PubMed ID: 11790217
[TBL] [Abstract][Full Text] [Related]
37. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents].
Pernet A; Bäbler M; Ganz K
Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361
[No Abstract] [Full Text] [Related]
38. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
39. [Sulfonylurea and alpha-glucosidase inhibitor].
Iijima T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():459-63. PubMed ID: 12387034
[No Abstract] [Full Text] [Related]
40. Diabetes Update: New Pharmacotherapy for Type 2 Diabetes.
Choby B
FP Essent; 2017 May; 456():27-35. PubMed ID: 28530382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]